Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 1 Published - 14:00 UTC    08:00 EST    13-September-2000      
Issue 153 Next Update - 14:00 UTC 08:00 EST    14-September-2000      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya



















Back To Vidyya Today In Vidyyasm

Newsletter Summary For 13-September-2000:

The Department of Health and Human Services (HHS) and the Association of Organ Procurement Organizations (AOPO) announced yesterday that the number of organ donors increased nearly 4 percent during the first half of 2000 compared to the first six months of 1999. This increase is similar to the positive trend reported for the first five months of the year by the United Network for Organ Sharing (UNOS).

This issue of Vidyya contains an in-depth look at organ donation from the patients' and hospitals' point-of-view. Included is a guide that can help answer a family's or patient's questions regarding organ donation, a downloadable copy of an organ donation card and other information about the organ donation process.

In other news, Medwave Inc. announced today that it has received 510(k) approval from the US Food and Drug Administration for its handheld blood pressure monitor, the Vasotrax. With this approval, Vasotrax is now available for sale in the United States. The new device is a fast and easy way for patient or practitioner to measure blood pressure and pulse from the radial artery on the wrist.

And finally, after yesterday's news about the hazards of Vioxx, there's news that a newer medication used to treat arthritis appears to have fewer deleterious side effects than some traditional therapies. In the study published in the Sept. 13 issue of the Journal of the American Medical Association (JAMA), Celebrex (celecoxib), a COX-2 inhbitor similar to Vioxx, fared better than ibuprofen.

The articles in today's Vidyya are:

As always, we hope you enjoy the issue.

Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 

Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.